Get the Stockscreener App
2.05
0.00%
0.00
After Hours:
2.05
Sera Prognostics Inc stock is traded at $2.05, with a volume of 76,816.
It is up +0.00% in the last 24 hours and up +13.89% over the past month.
Sera Prognostics Inc is a health diagnostic company. It is a women's health company utilizing the proprietary proteomics and bioinformatics platform, and data resources to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. The Company operates as one operating segment, which is developing and commercializing its medical diagnostic products and services.
See More
Previous Close:
$2.05
Open:
$2.05
24h Volume:
76,816
Relative Volume:
1.51
Market Cap:
$80.28M
Revenue:
$57,000
Net Income/Loss:
$-32.14M
P/E Ratio:
-3.1704
EPS:
-0.6466
Net Cash Flow:
$-27.58M
1W Performance:
-2.38%
1M Performance:
+13.89%
6M Performance:
-31.67%
1Y Performance:
-36.92%
1-Day Range:
$1.95
$2.21
1-Week Range:
$1.95
$2.30
52-Week Range:
$1.56
$3.95
Sera Prognostics Inc Stock (SERA) Company Profile
Name
Sera Prognostics Inc
Sector
Industry
Phone
(801) 990-0520
Address
2749 E. PARLEYS WAY, SALT LAKE CITY
Compare SERA vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SERA
Sera Prognostics Inc
|
2.05 | 80.28M | 57,000 | -32.14M | -27.58M | -0.6466 |
ABT
Abbott Laboratories
|
104.49 | 179.51B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
336.74 | 126.60B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
84.22 | 106.51B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
45.51 | 65.77B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
83.04 | 47.58B | 6.30B | 1.07B | 1.09B | 1.8406 |
Sera Prognostics Inc Stock (SERA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-15-25 | Initiated | Jefferies | Buy |
| Mar-30-22 | Downgrade | Citigroup | Buy → Neutral |
| Nov-19-21 | Initiated | Oppenheimer | Outperform |
| Oct-15-21 | Resumed | Cowen | Outperform |
Sera Prognostics Inc Stock (SERA) Latest News
Sera Prognostics Inc (SERA) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
SERA|Sera Prognostics Inc|Price:2.100|Chg%:+0.050 - TradingKey
Sera Prognostics Inc (SERA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Sera Prognostics Inc (SERA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
TradingKey - TradingKey
Sera Prognostics Inc (SERA) Income Statement - TradingKey
SERA|Sera Prognostics Inc|Price:2.050|Chg%:-0.120 - TradingKey
Sera Prognostics Inc. (SERA) Q1 2026 Earnings: In-Line Loss as Pre-Revenue Diagnostics Firm Continues DevelopmentProfit Warning Alert - dars.gov.et
Aberdeen Group plc's Strategic Acquisition of Sera Prognostics I - GuruFocus
Sera Prognostics study shows NICU admission cut in first births By Investing.com - Investing.com Nigeria
abrdn Group holds 7.21% of Sera Prognostics (SERA) stock - Stock Titan
Sera Prognostics Q1 2026 Earnings: EPS Matches Estimates, No Revenue, Stock Jumps 9%Earnings Volatility Report - dars.gov.et
Form 4 Sera Prognostics Inc For: 14 July By Investing.com - Investing.com South Africa
Sera Prognostics grants RSUs and options to director | SERA Insider Trading - Stock Titan
Sera Prognostics (SERA) director receives RSU and stock option grants - Stock Titan
Equity grants: Sera Prognostics (SERA) awards RSUs and options - Stock Titan
Sera Prognostics (SERA) grants RSUs and stock options to director Kim Kamdar - Stock Titan
Sera Prognostics (SERA) grants RSUs and options to director - Stock Titan
Sera Prognostics (SERA) awards RSUs and $1.97 stock options to director - Stock Titan
Sera Prognostics (SERA) grants new RSUs and stock options - Stock Titan
Sera Prognostics study shows NICU admission cut in first births - Investing.com
PRIME SUBGROUP ANALYSIS DEMONSTRATES 22% REDUCTION IN NICU ADMISSIONS IN FIRST-TIME PREGNANCIES USING PreTRM® Test-GUIDED CARE - PR Newswire
Sera Prognostics Q1 2026 Earnings: In-Line Results as Preterm Birth Diagnostic Company Continues Pre-Revenue PhaseEarnings Miss Streak - DonanımHaber
Sera Prognostics Among 3 Intriguing Penny Stocks To Consider - simplywall.st
SERASera Prognostics Inc Options - Finviz
Director Mark Christopher Capone files Form 3 for Sera Prognostics (SERA) - Stock Titan
Sera Prognostics, Inc. Class A Actuals & Estimates (NASDAQ:SERA) - TradingView
Sera Prognostics adds former Myriad Genetics CEO to board By Investing.com - Investing.com South Africa
Sera Prognostics, Inc. Appoints Mark Capone as Class II Director and Member of Compensation Committee, Effective as of July 1, 2026 - marketscreener.com
Sera Prognostics adds former Myriad Genetics CEO to board - Investing.com
Sera Prognostics Adds Veteran Executive to Board - TipRanks
Mark Capone appointed to Sera Prognostics board, joins Compensation Committee - TradingView
Veteran diagnostics leader Mark Capone joins Sera Prognostics (NASDAQ: SERA) board - Stock Titan
SERA PROGNOSTICS ANNOUNCES APPOINTMENT OF MARK CAPONE TO ITS BOARD OF DIRECTORS - Nasdaq
Sera Prognostics (SERA) Edges Higher as Stock Tests Key Resistance LevelStop Run - dars.gov.et
Sera Prognostics, Inc.(NasdaqGM:SERA) added to Russell Microcap Value Benchmark Index - marketscreener.com
Sera Prognostics, Inc.(NasdaqGM: SERA) added to Russell 3000E Value Benchmark - marketscreener.com
Sera Prognostics, Inc. Class A Actuals & Estimates (BOATS:SERA) - TradingView
SERA Forecast — Price Target — Prediction for 2027 - TradingView
Sera Prognostics (SERA) loses 27% in 4 weeks, here's why a trend reversal may be around the corner - MSN
Price to earnings forward of Sera Prognostics, Inc. – NASDAQ:SERA - TradingView
Enterprise value to revenue forward of Sera Prognostics, Inc. – NASDAQ:SERA - TradingView
Price to sales forward of Sera Prognostics, Inc. – NASDAQ:SERA - TradingView
SERA PROGNOSTICS COLLABORATES ON ARPA-H AWARD TO ADVANCE POINT-OF-CARE DIAGNOSTIC FOR SAFER BIRTH - PR Newswire
Price to book forward of Sera Prognostics, Inc. – NASDAQ:SERA - TradingView
Enterprise value to EBIT forward of Sera Prognostics, Inc. – BOATS:SERA - TradingView
Illinois expands Medicaid coverage for preterm birth tests By Investing.com - Investing.com South Africa
Illinois expands Medicaid coverage for preterm birth tests - Investing.com UK
SERA APPLAUDS ILLINOIS INITIATIVE TO EXPAND MEDICAID COVERAGE FOR PROTEOMIC BLOOD TESTING IN PREGNANCY - PR Newswire
Sera Prognostics Q1 2026 Earnings: In-Line Loss Highlights Pre-Revenue ProgressOperating Margin Analysis - dars.gov.et
All you need to know about Sera Prognostics (SERA) rating upgrade to buy - MSN
Sera Prognostics Inc Stock (SERA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.79%
4.39%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):